2021 iHEA Congress
iHEA update event: key dates and links
COVID-19 has become the most researched disease outbreak in history. Evidence on the financing, costs and impact of COVID-19 is critical in supporting countries across the world in planning their COVID-19 response.
We have built C19economics.org as a platform to enable, improve and share health economics evidence to inform COVID-related decision making and policies globally, with a focus on low and middle income countries (LMICs).
Functionalities of the platform
-
A repository with pre-identified literature
We screened over 12,000 resources to present you with this living repository of literatures on health economics
-
A news and blogs page
Learn about your colleagues’ views and share your own through this page
-
A methods and tools page with useful external resources
We worked with colleagues to identify a set of resources to support researchers and decision-makers on generating or commissioning new evidence
-
Forum to connect to one another
In addition to our researchers phone book, we have a put together a forum where you can share queries and your experience
latest news
Protected: COVID-19 vaccination Costing and Financing in low-income countries and lower-middle-income countries
HITAP & MORU’s work on vaccine HTA
What does the COVID-19 experience teach us about using models for a policy response to pandemics: A perspective from the COVID-19 Multi-model Comparison Collaboration (CMCC)
The COVID-19 Multi-model Comparison Collaboration (CMCC) is a unique initiative that provides guidance and standards for policy use of COVID-19 models.
Our Funders
This platform has been funded by the Bill and Melinda Gates Foundation, Wellcome Trust, UK Foreign Commonwealth and Development Office and is supported by the International Decision Support Initiative (Center for Global Development, London School of Hygiene and Tropical Medicine, HITAP)
